Obdobje:
Levente Kollár ... [et al].Fragment-based design of targeted covalent inhibitors: the scope and limitation of linkingChemMedChem, 2026, Vol. 21, iss. ,10 [article no.] e202501108, 2026, str. 1-16https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.202501108
Katarzyna Grychowska ... [et al.]Novel 1H-imidazo[4,5-c]quinoline derivatives as TLR-7 modulators with pro-apoptotic properties in breast cancer cell lineBioorganic & Medicinal Chemistry, 2026, Vol. 139, [article no.] 118700, Aug. 2026, str. 1-14https://www.sciencedirect.com/science/article/abs/pii/S0968089626001562
Troy Matziol ... [et al.]Design, synthesis and biological evaluation of novel pyrimidine and quinazoline-based small-molecule Toll-like receptor 8 antagonists European journal of medicinal chemistry, 2026, Vol. 311, [article no.] 118822, 2026, str. 1-20https://www.sciencedirect.com/science/article/pii/S0223523426002679
Joško Osredkar ... [et al.]Urinary porphyrin profiles and trace element imbalances in children with autism spectrum disorders: insights into environmental and metabolic biomarkersInternational journal of molecular sciences, 2025, Vol. 26, iss. 21, [article no.] 10478, Sep. 2025, 18 str.https://www.mdpi.com/1422-0067/26/21/10478
Joško Osredkar ... [et al.]Urinary uremic toxin signatures and the metabolic index of gut dysfunction (MIGD) in autism spectrum disorder: a stool-phenotype-stratified analysisInternational journal of molecular sciences, 2025, Vol. 26, iss. 21, [article no.] 10475, Sep. 2025, 14 str.https://www.mdpi.com/1422-0067/26/21/10475
Nika Strašek Benedik ... [et al.]Synthesis and structure-activity relationship study of novel quinazolin-4(3H)-one derivatives as Toll-like receptor 7 and 8 agonists with immunomodulatory activityEuropean journal of medicinal chemistry, 2025, Vol. 302, art. no. 118360, Jan. 2026, 1-24 str.https://www.sciencedirect.com/science/article/pii/S0223523425011250
Elisa Milandri ... [et al.]Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluationAnalytical and bioanalytical chemistry, 2025, (Nov. 2025, Vol. 418, str. 1-11)https://link.springer.com/article/10.1007/s00216-025-06169-4?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20251119&utm_content=10.1007/s00216-025-06169-4
Hubert Dirven ... [et al.]Hazard identification and characterization of leachable chemicals from plastic products – a new PARC projectFrontiers in toxicology, 2025, Vol. 7, [art. no.] 1719035, Nov. 2025, 1-12 str.https://www.frontiersin.org/journals/toxicology/articles/10.3389/ftox.2025.1719035/full
Peter Mastnak-Sokolov ... [et al.]Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and α7 nicotinic receptorChemico-biological Interactions, 2026, Vol. 423, [art. no.] 111830, Jan. 2026, 1-15 str.https://www.sciencedirect.com/science/article/pii/S0009279725004600
Lucija Ana Vrščaj, Janja Marc, Barbara OstanekDifferential expression of lncRNAs and mRNAs in bone marrow-derived mesenchymal stem cells under continuous and intermittent teriparatide treatmentBiomedicine & pharmacotherapy, 2025, Vol. 189, art. no. 118293, Aug. 2025, 1-11 str.https://www.sciencedirect.com/science/article/pii/S0753332225004871